Allergy and covid-19
- De Filippo M.
- Votto M.
- Brambilla I.
- Castagnoli R.
- Montagna L.
- Caffarelli C.
- Cardinale F.
- Del Giudice M. M.
- Tosca M.
- Caimmi S.
- Licari A.
- Marseglia G. L.
DOIAbstract
The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult popula-tion, whereas a mild course was observed in childhood. Allergic diseases, characterized by a type-2 polariza-tion of the immune system, were considered one of the major risk factor of severe COVID-19. Large amounts of clinical data and expert opinions have been collected since the pandemic outbreak. This review summarizes the latest insights on COVID-19 and allergy. (www.actabiomedica.it)
Add to ORKG